Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Rein Therapeutics (RNTX) Debt to Equity (2018 - 2021)

Rein Therapeutics (RNTX) has disclosed Debt to Equity for 3 consecutive years, with $0.01 as the latest value for Q1 2021.

  • On a quarterly basis, Debt to Equity changed N/A to $0.01 in Q1 2021 year-over-year; TTM through Mar 2021 was $0.01, a N/A change, with the full-year FY2020 number at $0.03, changed N/A from a year prior.
  • Debt to Equity was $0.01 for Q1 2021 at Rein Therapeutics, down from $0.03 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.27 in Q4 2018 to a low of $0.01 in Q1 2021.
  • A 3-year average of $0.09 and a median of $0.03 in 2020 define the central range for Debt to Equity.